{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-054315","form_type":"8-K","ticker":"INM","cik":"0001728328","company_name":"InMed Pharmaceuticals Inc.","filed_at":"2025-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.494675+00:00","generated_at":"2026-05-19T08:39:52.738540+00:00","sec_items":["1.01","4.01","5.07","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"InMed special meeting lacks quorum for share issuance vote; appoints new auditor CBIZ","bullets":["Special meeting on June 13, 2025 lacked quorum; ~60% of voted shares favored share issuance proposal but no vote held. Board evaluating next steps.","Marcum resigned as auditor after acquisition by CBIZ; Board appointed CBIZ as independent auditor for FY2025. No disagreements; prior material weakness remediated.","Company amended SEPA with Yorkville to allow suspension of registration statement during black-out periods, subject to restrictions similar to insider trading policies."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-054315","json":"https://secwatch.observer/filing/0001213900-25-054315.json","markdown":"https://secwatch.observer/filing/0001213900-25-054315.md","text":"https://secwatch.observer/filing/0001213900-25-054315.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025054315/0001213900-25-054315-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025054315/ea0245506-8k_inmed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T08:39:52.738540+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}